These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23012995)

  • 1. [Correction of bioenergetic processes in small intestine during experimental widespread purulent peritonitis].
    Kosinets VA
    Eksp Klin Farmakol; 2012; 75(8):39-43. PubMed ID: 23012995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis].
    Kosinets VA
    Eksp Klin Farmakol; 2010 Jan; 73(1):30-2. PubMed ID: 20184286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic immunocorrection treatment of experimental widespread purulent peritonitis].
    Gostishchev VK; Kosinets VA; Matusevich EA; Adamenko GP
    Eksp Klin Farmakol; 2012; 75(2):42-6. PubMed ID: 22550860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correction of protein-lipid composition in liver mitochondria during experimental widespread purulent peritonitis].
    Kosinets VA; Osochuk SS; Iarotskaia NN
    Eksp Klin Farmakol; 2012; 75(3):31-4. PubMed ID: 22679751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic correction of the lipid-transport system in experimental diffuse purulent peritonitis].
    Kosinets VA
    Vestn Khir Im I I Grek; 2012; 171(3):92-6. PubMed ID: 22880442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Free-radical oxidation in liver during experimental widespread purulent peritonitis].
    Kosinets VA; Iarotskaia NN
    Eksp Klin Farmakol; 2012; 75(10):37-41. PubMed ID: 23240157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of reamberin for correction of enterocyte functional activity in experimental disseminated purulent peritonitis].
    Kosinets VA
    Eksp Klin Farmakol; 2010 Feb; 73(2):35-8. PubMed ID: 20369600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological correction of free radical disturbances and endotoxicosis in patients with diffuse peritonitis at the postoperative period].
    Bagnenko SF; Mirzabaev AT; Batotsyrenov BV; Gorbachev NB; Miroshnichenko VN; Batotsyrenova KhV; Velikiĭ KF
    Vestn Khir Im I I Grek; 2011; 170(5):14-6, 18. PubMed ID: 22238957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels].
    Bogomolov MS; Sedov VM; Edovina LN; Luk'ianov IuV; Slobodianiuk VV
    Vestn Khir Im I I Grek; 2011; 170(1):43-6. PubMed ID: 21506354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic correction of structural changes in adrenal glands during experimental widespread purulent peritonitis].
    Kosinets VA; Fedotov DN
    Eksp Klin Farmakol; 2012; 75(6):44-7. PubMed ID: 22891442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antioxidant therapy in discirculatory encephalopathy].
    Antipenko EA; Gustov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative experimental study of antioxidant efficiency in treatment of acute pancreatitis].
    Kliuĭko DA; Korik VE; Zhidkov SA
    Eksp Klin Farmakol; 2011; 74(9):11-5. PubMed ID: 22164440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency].
    Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correction of a reperfusion dysfunction in acute intestinal obstruction].
    Bagnenko SF; Sinenchenko GI; Kurygin AA; Chupris VG
    Vestn Khir Im I I Grek; 2008; 167(4):32-5. PubMed ID: 18942433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin].
    Madzhidova EN; Usmanova DD; Baĭtursunova ZhM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience of cytoflavin administration for treating acute carbon monoxide poisoning].
    Zobnin IuV; Petrova AG; Provado IP; Afanas'ev VV
    Eksp Klin Farmakol; 2011; 74(10):39-42. PubMed ID: 22238986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positive effect of cytoflavin on metabolic status changes in patients with burn disorder].
    Polutova NV; Ostrovskiĭ NV; Romantsov MG; Chesnokova NP
    Eksp Klin Farmakol; 2011; 74(7):33-7. PubMed ID: 21894767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome].
    Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficiency of intensive care with cytoflavin in patients of advanced age in combined traumatic brain injury].
    Lebedeva EA; Belousova ME; Kurtasov AA; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL
    Adv Gerontol; 2014; 27(3):578-83. PubMed ID: 25827011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of cytoflavin for the treatment of chronic brucellosis].
    Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV
    Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.